NCT00516243 - Defined Green Tea Catechin Extract in Treating Women With Hormone Receptor Negative Stage I-III Breast Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions

Estrogen Receptor-negative Breast CancerProgesterone Receptor-negative Breast CancerStage I Breast CancerStage II Breast CancerStage IIIA Breast CancerStage IIIB Breast Cancer

Interventions

OTHER

placebo

Given PO

OTHER

quality-of-life assessment

Ancillary studies

PROCEDURE

questionnaire administration

Ancillary studies

PROCEDURE

laboratory biomarker analysis

Correlative studies

DRUG

defined green tea catechin extract

Given PO

Trial Locations (4)

10032

Columbia University Medical Center, New York

10065

Memorial Sloan-Kettering Cancer Center, New York

77030

Baylor College of Medicine, Houston

M D Anderson Cancer Center, Houston

All Listed Sponsors

collaborator

National Institutes of Health (NIH)

NIH

lead

National Cancer Institute (NCI)

NIH